Ioxilan is a diagnostic contrast agent. It is injected intravenously before taking X-ray images to increase arterial contrast in the final image. It was marketed in the US under the trade name Oxilan by Guerbet, L.L.C., but was discontinued in 2017.Oxilan . Accessed 2021-04-07.
Mechanism of action Ioxilan is an iodinated contrast agent.
References